Genovate Biotechnology Co., Ltd.,
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Genovate Biotechnology Co., Ltd., sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Genovate Biotechnology Co., Ltd.,: 5 sponsored US clinical trials, none currently recruiting.
Genovate Biotechnology Co., Ltd., sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Intermittent Claudication, with 1 trials.
Upper-quartile sponsor footprint
Genovate Biotechnology Co., Ltd., sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers
NCT06167265
BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
NCT05466734
Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers
NCT05191862
Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
NCT03864666
Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
NCT03480321
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
Therapeutic Areas
How the Genovate Biotechnology Co., Ltd., early-phase archive is shaped
5 indexed studies, none listed as recruiting (0% open); 4 completed (80%).
Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Intermittent Claudication (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Genovate Biotechnology Co., Ltd.,: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Genovate Biotechnology Co., Ltd., sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Genovate Biotechnology Co., Ltd., page
5 registered trials is a research-attention snapshot, not an endorsement of Genovate Biotechnology Co., Ltd., or any single study.
- None of Genovate Biotechnology Co., Ltd.,'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Intermittent Claudication is the condition Genovate Biotechnology Co., Ltd., studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Intermittent Claudication trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Genovate Biotechnology Co., Ltd., pipeline card: 5 registered trials from official public datasets.Report a data error.